Clinical trial Recruiting at 1 site Observational Ages 18 to 100

Survey of physical activity and quality of life for people with fibromuscular dysplasia

Official title: National Survey of Physical Activity Restrictions and Quality of Life Among Patients With Fibromuscular Dysplasia

Run by Vanderbilt University Medical Center · NCT07529691 · Data updated 2026-11-12

This national survey asks adults with fibromuscular dysplasia to see if activity restrictions affect their quality of life and emotional well-being.

More Spontaneous Coronary Artery Dissection trials

Quick facts

Study typeObservational
Ages18 Years to 100 Years
SexAll
Enrollment2000 (estimated)
SponsorVanderbilt University Medical Center
Academic / other
Locations1 site (Nashville, Tennessee)
StatusRecruiting
StartedApril 14, 2026
Main results expectedApril 30, 2027
Study endsJune 30, 2027
Registry record updatedApril 20, 2026
Trial IDNCT07529691 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–100 with a diagnosis of fibromuscular dysplasia who can read English and complete an online survey are ideal candidates.

Probably not a fit

People who cannot complete electronic consent or the online survey, non-English speakers, or those without a diagnosis of FMD are unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study will deliver an electronic REDCap survey to adults who self-identify as having fibromuscular dysplasia to document the types of physical activity recommendations they received and how those recommendations affect daily life and emotions. The survey targets a broad, national population of English-speaking participants aged 18–100 and collects information on activity limits, counseling sources, and quality-of-life impacts. Because current guidance is based largely on expert opinion and varies across providers, the study aims to map real-world advice and its consequences for patients. Results will summarize the breadth of recommendations and their reported effects to inform future guidance and patient counseling.

Why it matters

Potential benefit: If successful, the findings could clarify common activity recommendations and support better counseling to improve quality of life for people with FMD.

How similar studies have gone: This approach is largely novel for FMD at a national scale, as existing guidance is expert opinion and there have been no large national surveys characterizing activity recommendations and their impacts.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion criteria:

* Participants with a diagnosis of fibromuscular dysplasia
* Age range = 18-100 years

Exclusion Criteria:

* Subjects who have an inability to complete the electronic consent form or electronic survey for any reason
* Subjects who are non-English speaking who cannot read the electronic consent form or electronic survey

Where it's running

  • Vanderbilt University Medical Center
    Nashville, Tennessee, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.